Study finds nanomedicine targeting lymph nodes key to triple negative breast cancer treatment
Research from the University of Michigan Rogel Cancer Center, USA, could provide a new approach…
Browsing: metastatic triple negative breast cancer
Sacituzumab govitecan receives positive CHMP opinion as 2L treatment for adult patients with metastatic triple-negative breast cancer
The Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for…
ESMO 2021: The KEYNOTE-355 study
Highlights on combination of pembrolizumab plus chemotherapy in metastatic triple-negative breast cancer: The KEYNOTE-355 study
FDA grants accelerated approval to sacituzumab govitecan-hziy for metastatic triple negative breast cancer
The Food and Drug Administration (FDA) granted accelerated approval to sacituzumab govitecan-hziy for adult patients…
New ‘smart drug’ shows promise for metastatic triple-negative breast cancer
A new “smart drug” has shown promise for women with metastatic triple-negative breast cancer, based…
‘Liquid biopsy’ can help predict outcomes in metastatic triple-negative breast cancer
A clinically relevant “liquid biopsy” test can be used to profile cancer genomes from blood…